UK pub group Fullers gears up for Christmas as bookings rise 11%
Britain's Fuller Smith & Turner said on Wednesday that its current bookings were already 11% ahead of last year, priming the pub group for a strong Christmas season....
Stay updated with breaking news from Eva Mathews. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Britain's Fuller Smith & Turner said on Wednesday that its current bookings were already 11% ahead of last year, priming the pub group for a strong Christmas season....
Imperial Brands said on Tuesday it expects operating profit to rise in low single digits for the first half of fiscal 2024, with performance picking up in the second half due to pricing actions...
Informa increased its full-year revenue and profit expectations on Tuesday, as the British events organiser bet on sustained demand for face-to-face interaction in its academic and B2B businesses. ...
British drugmaker GSK on Monday said the human medicines committee of the European Medicines Agency had recommended approving its oral therapy to treat anaemia in patients with a type of bone marrow cancer called myelofibrosis. A decision for the marketing authorization of the therapy, momelotinib, is expected by early 2024, GSK said in a statement.
Shares in the world's largest spirits company fell 8.5% to 2,970 pence in early trading, making it the top loser on London's blue-chip index. Sales in the Latin America and Caribbean (LAC) market, which generates nearly 11% of total sales, are now expected to decline by more than 20% in the six months ended December, the company added. Meanwhile in Europe, growth continues to be strong despite geopolitical tensions in the Middle East, albeit the pace is slower than the second half of the previous financial year, Diageo said.